Covaxin
Vaccine against COVID-19
Covaxin ▸ Facts ▸ Comments ▸ News ▸ Videos
Covaxin is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.
| 1 shares | ShareTweetSavePostSend |
You Might Like
Covovax for adults to reach metros in a week: SIISerum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..IndiaTimes - Published | |
Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseCovovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had approved the market authorisation for Covovax..IndiaTimes - Published | |
Drug panel favours nod for Covovax as Covid boosterAn expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have..IndiaTimes - Published | |
Covovax may get approval as heterologous boosterThe government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for..IndiaTimes - Published | |
Ocugen-Bharat Biotech Covid vaccine Covaxin meets main goals in US trialOcugen Inc said on Monday the Covid-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United States. The vaccine, sold under brand name..IndiaTimes - Published | |
Noida residents experience vaccination shortage: Check where Covid-19 vaccine, booster dose are availableNoida residents experienced shortage of Covaxin and Covishield on Saturday, check out where you can get Covid-19 vaccine and booster dose.DNA - Published | |
Indian govt, Bharat Biotech rubbish reports of Covaxin development being rushed under political pressureIndiaTimes - Published | |
Govt: Sputnik V recipients can take Covishield, Covaxin boosterIndiaTimes - Published | |
Corbevax gets nod as booster after Covishield, Covaxin shotsIndiaTimes - Published | |
India to start Covid mix-and-match booster vaccines on FridayIndia said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and AstraZeneca's..IndiaTimes - Published | |
Biological E's Corbevax approved as booster dose for adults vaccinated with Covaxin, CovishieldThis is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in India.DNA - Published Also reported by •IndiaTimes | |
Govt nod for Corbevax as booster for adults vaccinated with Covishield, Covaxin soonIndiaTimes - Published | |
Japan allows Covaxin boosted travellers to visit countryIndiaTimes - Published | Biological E's Corbevax, Bharat Biotech's Covaxin get NTAGI's nod for use children aged 5-12 yearsPrime Minister Narendra Modi emphasised that all eligible children get the Covid-19 vaccine as soon as possible via "special programmes" in schools.DNA - Published |
NTAGI approves Corbevax, Covaxin for 5-12 years age group: SourcesIndiaTimes - Published | Corbevax being considered as booster dose for Covishield, Covaxin jabbed peopleNTAGI is considering using Corbevax as a booster vaccination against Covid-19.DNA - Published |
Covaxin safe for 2-18 age group: BB studyIt conducted phase II/III, open-label, and multicentre study to evaluate the safety, reactogenicity and immunogenicity of Covaxin in children and adolescents in the 2-18 years of age group between..IndiaTimes - Published | Covaxin booster beats back Delta, Omicron variants: NIVThe researchers compared the efficacy of Covaxin after the second and third doses against the Delta variant, and also studied its efficacy against the Omicron variants in a Syrian hamster model.IndiaTimes - Published |
Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants: ICMR studyThe findings of the study by ICMR have been published on Tuesday on bioRxiv, a pre-print server and have not been peer-reviewed.DNA - Published Also reported by •IndiaTimes | NTAGI to discuss allowing Corbevax as booster shot for Covishield, Covaxin recipients: SourcesAllowing Biological E's Corbevax as a booster for those fully vaccinated against Covid-19 with either Covishield or Covaxin and reducing the gap between the second dose and the precaution dose of the..IndiaTimes - Published |
FDA lifts hold on Covaxin's clinical trials in USThe US Food and Drug Administration which has put on hold the phase 2/ 3 clinical trials of Bharat Biotech's Covid-19 vaccine Covaxin, in USA, has lifted the pause, according to a statement issued by..IndiaTimes - Published | Covaxin Phase 2&3 trials to resume in US after USFDA lifts clinical holdThe US Food and Drug Administration (USFDA) has lifted the clinical hold on the Phase 2 and 3 immuno-bridging clinical trials of Bharat Biotech’s Covid-19 vaccine Covaxin that were being conducted in..IndiaTimes - Published |
Corbevax maker seeks emergency use approval as booster jab for adults vaccinated with Covishield, CovaxinThere were 416 patients aged 18 to 80 who got two doses of Covaxin or Covishield, the last one six months before the Corbevax booster.DNA - Published | Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-oldBharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI...IndiaTimes - Published |
Bharat Biotech must address WHO's Covaxin suspension to avoid EUL cancellation, says MEAWeeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world..IndiaTimes - Published | DCGI gives approval for Bharat Biotech's Covaxin for children aged 6-12The Drug Controller General of India (DCGI) has given a restricted emergency use approval for Bharat Biotech's Covid-19 vaccine, Covaxin, for children between the age of six and 12. A Subject Expert..IndiaTimes - Published Also reported by •DNA |
DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age groupThe Drug Controller General of India (DCGI) on Tuesday granted emergency use approval to Covid-19 vaccines, Covaxin and Corbevax, for children below 12. Bharat Biotech's Covaxin has got nod for use in..IndiaTimes - Published | Bharat Biotech asked to provide more data on Covid-19 vaccine Covaxin for children aged below 12The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its Covid-19 vaccine, Covaxin, for administering it to children aged..IndiaTimes - Published |
Fallout of WHO observations: Covaxin's Phase 2/3 trials in US put on holdThe US Food and Drug Administration has put on hold the phase 2/3 clinical trials of Bharat Biotech's Covid-19 vaccine Covaxin, in USA. Bharat Biotech's partner for US and Canada for Covaxin, the FDA's..IndiaTimes - Published | Covid Update: Get Covaxin, Covishield at Rs 225Price slash of Covaxin and Covishield was announced after the government allowed all above 18 years of age can get booster dose from April 10.DNA - Published |
Bharat Biotech, SII slash prices of Covaxin, Covishield booster dose to Rs 225 per shotIndiaTimes - Published | Covishield, Covaxin prices slashed ahead of booster drive expansionSerum Institute of India has reduced the price of its Covishield vaccine from Rs 600 to Rs 225 per dose for private hospitals, the vaccine maker announced on Saturday. Bharat Biotech also slashed the..IndiaTimes - Published |
Japan recognises Covaxin to facilitate travel from April 10: Bharat BiotechIndiaTimes - Published | High immune response to Covid variants in breakthrough cases after 2 Covaxin jabs: ICMR studyIn a recent ICMR study, breakthrough cases after full vaccination with Covaxin have shown a significant increase in the immune response against coronavirus' variants of concern -- Beta, Delta and..IndiaTimes - Published |
'Amid drop in demand, Bharat Biotech slowed Covaxin production since February'IndiaTimes - Published | WHO suspension not to impact Covaxin as no supplies to any UN agency yetIndiaTimes - Published |
No impact of WHO action on Covaxin, have not supplied to any UN agency: Bharat BiotechWith WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and..IndiaTimes - Published | SII's Covovax becomes the fourth jab to be used for vaccination of 12-17 age groupCovovax is the 4th Covid vaccine authorised for administration in 12 years and above after ZyCoV-D, Bharat Biotech's Covaxin, Biological E's Corbevax.DNA - Published |
WHO suspends Covaxin supply, rules out safety fearsIndiaTimes - Published | WHO suspends Covaxin supply for UN procurement citing GMP deficiencies at Bharat Biotech facilitiesIndiaTimes - Published |
Slowing down Covaxin output across plants for maintenance, process & facility optimisation: Bharat BiotechBharat Biotech on Friday announced the temporary slowing down of production of its Covid-19 vaccine Covaxin across its manufacturing facilities as it has completed its supply obligations to procurement..IndiaTimes - Published | ICMR study shows increase in antibodies after receiving Covaxin booster dose, says MoS HealthInternational data available on booster doses of AstraZeneca & Covishield suggests 3 to 4 fold increase in antibody levels after their administration.DNA - Published |
Haffkine's rollout of Covaxin not likely till end of this yearIndiaTimes - Published | Mixing Covishield & Covaxin gives better immunity: ICMRIndiaTimes - Published |
Qatar sets ‘immunity validity period’: 9 months for Covishield & 6 months for Covaxin last shotIndiaTimes - Published | USFDA paves way for Covaxin trials in USIndiaTimes - Published |
USFDA lifts clinical hold on Ocugen's IND application for Covaxin paving way for its evaluation for US marketIndiaTimes - Published | |
